Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Oscar Health Inc’s stock clocked out at $15.68, down -0.06% from its previous closing price of $15.69. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 5.32 million shares were traded. OSCR stock price reached its highest trading level at $15.8 during the session, while it also had its lowest trading level at $15.29.
Ratios:
To gain a deeper understanding of OSCR’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
On January 05, 2026, Barclays Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $18.
On December 11, 2025, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $17.Stephens initiated its Equal-Weight rating on December 11, 2025, with a $17 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 08 ’26 when Schlosser Mario sold 23,038 shares for $17.65 per share. The transaction valued at 406,621 led to the insider holds 350,180 shares of the business.
Schlosser Mario sold 76,962 shares of OSCR for $1,309,124 on Jan 06 ’26. The President of Technology & CTO now owns 350,180 shares after completing the transaction at $17.01 per share. On Jan 06 ’26, another insider, MARIO SCHLOSSER, who serves as the Director of the company, bought 100,000 shares for $16.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 4515168768 and an Enterprise Value of 1853817856. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 4.00. Its current Enterprise Value per Revenue stands at 0.164 whereas that against EBITDA is -10.293.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.90, which has changed by -0.038036823 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.80, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -0.84%, while the 200-Day Moving Average is calculated to be -3.97%.
Shares Statistics:
It appears that OSCR traded 11.72M shares on average per day over the past three months and 9259780 shares per day over the past ten days. A total of 225.78M shares are outstanding, with a floating share count of 210.80M. Insiders hold about 20.36% of the company’s shares, while institutions hold 53.70% stake in the company. Shares short for OSCR as of 1767139200 were 25105529 with a Short Ratio of 2.14, compared to 1764288000 on 31317201. Therefore, it implies a Short% of Shares Outstanding of 25105529 and a Short% of Float of 10.92.
Earnings Estimates
. The current rating of Oscar Health Inc (OSCR) reflects the combined expertise of 8.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.68, with high estimates of $1.19 and low estimates of $0.43.
Analysts are recommending an EPS of between -$1.19 and -$1.42 for the fiscal current year, implying an average EPS of -$1.29. EPS for the following year is $0.0, with 7.0 analysts recommending between $0.44 and -$0.39.
Revenue Estimates
In. The current quarter, 9 analysts expect revenue to total $3.12B. It ranges from a high estimate of $3.21B to a low estimate of $3.04B. The current estimate, Oscar Health Inc’s year-ago sales were $2.39BFor the next quarter, 9 analysts are estimating revenue of $3.26B. There is a high estimate of $3.74B for the next quarter, whereas the lowest estimate is $2.85B.
A total of 9 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.1B, while the lowest revenue estimate was $11.93B, resulting in an average revenue estimate of $12.02B. In the same quarter a year ago, actual revenue was $9.18BBased on 9 analysts’ estimates, the company’s revenue will be $12.76B in the next fiscal year. The high estimate is $14.98B and the low estimate is $11.38B.
